Paper41377642
Gut Microbiome and Cardiovascular Health: Mechanisms, Therapeutic Potential and Future Directions.
Edpuganti S and 4 others. Heart Int, 2025. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Gut Microbiome and Cardiovascular Health: Mechanisms, Therapeutic Potential and Future Directions. Papers, record 41377642. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41377642
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Gut Microbiome and Cardiovascular Health: Mechanisms, Therapeutic Potential and Future Directions.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References100
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36524472 | Gut Microbiota-Generated Phenylacetylglutamine and Heart Failure. | Circ Heart Fail | 2023 | https://conductscience.org/library/papers/36524472 | PubMed |
| 2 | 32762536 | Gut Microbiota and Cardiovascular Disease. | Circ Res | 2020 | https://conductscience.org/library/papers/32762536 | PubMed |
| 3 | 33689000 | The gut microbiome of laboratory mice: considerations and best practices for translational research. | Mamm Genome | 2021 | https://conductscience.org/library/papers/33689000 | PubMed |
| 4 | 36704458 | Alteration of the gut microbiota and metabolite phenylacetylglutamine in patients with severe chronic heart failure. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/36704458 | PubMed |
| 5 | 26972052 | Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk. | Cell | 2016 | https://conductscience.org/library/papers/26972052 | PubMed |
| 6 | 36982880 | Modulation of Endothelial Function by TMAO, a Gut Microbiota-Derived Metabolite. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982880 | PubMed |
| 7 | 40410854 | Fecal microbiota transplantation for hypertension: an exploratory, multicenter, randomized, blinded, placebo-controlled trial. | Microbiome | 2025 | https://conductscience.org/library/papers/40410854 | PubMed |
| 8 | 39765880 | Polyphenol-Derived Microbiota Metabolites and Cardiovascular Health: A Concise Review of Human Studies. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39765880 | PubMed |
| 9 | 34436434 | Exploring the Gut Microbiota and Cardiovascular Disease. | Metabolites | 2021 | https://conductscience.org/library/papers/34436434 | PubMed |
| 10 | 37229456 | Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37229456 | PubMed |
| 11 | 33803407 | The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies. | Nutrients | 2021 | https://conductscience.org/library/papers/33803407 | PubMed |
| 12 | 31182162 | Sex, gut microbiome, and cardiovascular disease risk. | Biol Sex Differ | 2019 | https://conductscience.org/library/papers/31182162 | PubMed |
| 13 | 30264354 | Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health. | Curr Nutr Rep | 2018 | https://conductscience.org/library/papers/30264354 | PubMed |
| 14 | 40155609 | The regulatory framework for microbiome-based therapies: insights into European regulatory developments. | NPJ Biofilms Microbiomes | 2025 | https://conductscience.org/library/papers/40155609 | PubMed |
| 15 | 36655084 | Long-term use of probiotics for the management of office and ambulatory blood pressure: A systematic review and meta-analysis of randomized, controlled trials. | Food Sci Nutr | 2023 | https://conductscience.org/library/papers/36655084 | PubMed |
| 16 | 36768264 | Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease? | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36768264 | PubMed |
| 17 | 30782617 | Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled-feeding trial. | Gut | 2019 | https://conductscience.org/library/papers/30782617 | PubMed |
| 18 | 33003455 | Gut Microbiota in Hypertension and Atherosclerosis: A Review. | Nutrients | 2020 | https://conductscience.org/library/papers/33003455 | PubMed |
| 19 | 30410105 | Dietary metabolism, the gut microbiome, and heart failure. | Nat Rev Cardiol | 2019 | https://conductscience.org/library/papers/30410105 | PubMed |
| 20 | 32010123 | Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy. | Front Immunol | 2019 | https://conductscience.org/library/papers/32010123 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42921018 | Gut microbiota-bile acid-immune axis: receptor signaling, metabolic regulation, and therapeutic translation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42921018 | PubMed |
| 42865986 | New insights into the gut-heart axis: microbial metabolite biomarkers, multi-omics, and engineered bacterial delivery systems. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42865986 | PubMed |
| 42769626 | Milk-derived extracellular vesicles in cardiovascular therapy: emerging biological functions and therapeutic perspectives. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/42769626 | PubMed |
| 42712928 | The gut microbiome-cardiometabolic axis: insights into obesity, type 2 diabetes, and hypertension. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42712928 | PubMed |
| 42639235 | Metabolic Syndrome: From Mechanisms to Therapeutic Interventions. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42639235 | PubMed |
| 42609637 | The gut-heart axis: a review of the mechanisms and therapeutic prospects of gut microbiota and their metabolites in cardiovascular disease. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42609637 | PubMed |
| 42416572 | Metabolic Dysfunction-Associated Steatotic Liver Disease as a Systemic Driver of Heart Failure With Preserved Ejection Fraction: Mechanistic Insights and Emerging Therapeutic Perspectives. | Rev Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42416572 | PubMed |
| 42353030 | Gut Microbiome-Hormone Interactions and Precision Fermentation in the Prevention of Early Cardiovascular Risk in Adolescents. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353030 | PubMed |
| 42351694 | Gut Microbiota as an Innovative Therapeutic Target in Cardiovascular Diseases from a Metabolic and Inflammatory Perspective. | Biomedicines | 2026 | https://conductscience.org/library/papers/42351694 | PubMed |
| 42305144 | Regenerative and molecular therapies for myocardial repair (Review). | Med Int (Lond) | 2026 | https://conductscience.org/library/papers/42305144 | PubMed |
| 42070004 | Medicinal Plants and the Gastrointestinal Microbiota in Chronic Diseases Modulation: A Structured Mechanistic and Translational Review. | Curr Microbiol | 2026 | https://conductscience.org/library/papers/42070004 | PubMed |
| 41598535 | Gut-Heart Axis and Infective Endocarditis: How Microbiota Dysbiosis Shapes Cardiovascular Risk and Infection Susceptibility. | J Clin Med | 2026 | https://conductscience.org/library/papers/41598535 | PubMed |
| 41596655 | Microbiota-Mediated Crosstalk Between the Gut and the Vascular System: Protective Effects of Novel Postbiotic Formulations on Human Endothelial and Vascular Smooth Muscle Cells. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596655 | PubMed |
| 41555935 | The Hepato-Cardio-Renal Axis in Cirrhosis: Hemodynamic and Mechanistic Insights, Diagnostic Biomarkers, and Expanding Therapeutic Horizons. | Discoveries (Craiova) | 2025 | https://conductscience.org/library/papers/41555935 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41377642
GET https://conductscience.org/api/papers/v1/41377642/references?page=2